UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 355

Sortiert nach

How I treat adenovirus in hematopoietic stem cell transplant recipients

Blood, 2010-12, Vol.116 (25), p.5476-5485

2010

Link zum Volltext

Verfügbarkeit prüfen

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Link zum Volltext

Verfügbarkeit prüfen

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Molecular therapy, 2017-01, Vol.25 (1), p.249-258

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Cancer discovery, 2018-08, Vol.8 (8), p.972-987

2018

Link zum Volltext

Verfügbarkeit prüfen

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Current opinion in infectious diseases, 2018-08, Vol.31 (4), p.292-300

2018

Link zum Volltext

Verfügbarkeit prüfen

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Blood, 2013-06, Vol.121 (26), p.5113-5123

2013

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

Cytotherapy (Oxford, England), 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

British journal of haematology, 2023-08, Vol.202 (4), p.874-878

2023

Link zum Volltext

Verfügbarkeit prüfen

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical cancer research, 2023-01, Vol.29 (2), p.324-330

2023

Link zum Volltext

Verfügbarkeit prüfen

Fine-tuning the CAR spacer improves T-cell potency

Oncoimmunology, 2016-12, Vol.5 (12), p.e1253656-e1253656

2016

Link zum Volltext

Verfügbarkeit prüfen

Antiviral T-cell therapy

Immunological reviews, 2014-03, Vol.258 (1), p.12-29

2014

Link zum Volltext

Verfügbarkeit prüfen

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

Haematologica (Roma), 2020-01, Vol.105 (1), p.235

2020

Link zum Volltext

Verfügbarkeit prüfen

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Clinical cancer research, 2017-07, Vol.23 (14), p.3499-3509

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

Molecular therapy, 2014-06, Vol.22 (6), p.1211-1220

2014

Link zum Volltext

Verfügbarkeit prüfen

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Molecular therapy, 2013-11, Vol.21 (11), p.2113-2121

2013

Link zum Volltext

Verfügbarkeit prüfen

Is cancer gene therapy an empty suit?

The lancet oncology, 2013-10, Vol.14 (11), p.e447-e456

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Blood, 2024-04, Vol.143 (17), p.1726

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Blood, 2014-06, Vol.123 (25), p.3895-3905

2014

Link zum Volltext

Verfügbarkeit prüfen

Improving T cell therapy for cancer

Annual Review of Immunology, 2007-01, Vol.25 (1), p.243-265

2007

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Blood, 2009-11, Vol.114 (19), p.4283-4292

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

Frontiers in immunology, 2023, Vol.14, p.1299512-1299512

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 355

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(331)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(178)
Humans
(126)
Female
(59)
Male
(55)
Immunotherapy
(45)
Immunology
(41)
Hematology
(40)
Medicine, Research & Experimental
(38)
Research & Experimental Medicine
(38)
Animals
(37)
Hematology, Oncology And Palliative Medicine
(34)
Oncology
(34)
T-Lymphocytes, Cytotoxic - Immunology
(32)
Adult
(30)
Biological And Medical Sciences
(29)
Middle Aged
(27)
Lymphocytes
(26)
Medical Sciences
(25)
Antigens
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How I treat adenovirus in hematopoietic stem cell transplant recipients

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Fine-tuning the CAR spacer improves T-cell potency

Antiviral T-cell therapy

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Is cancer gene therapy an empty suit?

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Improving T cell therapy for cancer

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

Aktive Filter

Suchergebnisse filtern